DGKA and neoplasm: Other references have also suggested the potential for DGKα inhibition to increase T cell activity against tumors [4,42,43,44,45], and recently DGKα inhibition has been shown to mitigate T cell exhaustion [46]—which may be a more prominent mechanism than anergy for weakening anti-tumor T cell activity.